Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.55 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.51 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6016752 | 0.94 | HPGD (0.54) | MAOBSMPD1HDAC1HDAC8HDAC6 | |
| SCHEMBL1646582 | 0.90 | RXRA (0.56) | SMPD1HDAC1HDAC8HDAC6HPGD | |
| SCHEMBL17747123 | 0.89 | MAOB (0.55) | MAOBSMPD1HDAC1HDAC8HDAC6 | |
| SCHEMBL8641451 | 0.89 | HPGD (0.57) | MAOBSMPD1HDAC1HDAC8HDAC6 | |
| SCHEMBL13312278 | 0.89 | MAOB (0.60) | MAOBSMPD1HDAC1HDAC8HDAC6 | |
| SCHEMBL131229 | 0.87 | FOLH1 (0.63) | MAOBHPGDSMN1; SMN2NPC1RAB9A | |
| SCHEMBL966146 | 0.87 | MAOB (0.52) | MAOBHPGDLMNASMN1; SMN2NPC1 | |
| SCHEMBL6687833 | 0.87 | HDAC8 (0.73) | SMPD1HDAC1HDAC8HDAC6HPGD | |
| SCHEMBL10735495 | 0.87 | SMN1; SMN2 (0.70) | SMPD1HDAC1HDAC8HDAC6HPGD | |
| SCHEMBL7178691 | 0.87 | AKR1C3 (0.49) | HPGDSMN1; SMN2NPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116693406-B | Preparation method of salbutamol sulfate | 山东锐顺药业有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-116836069-B | Preparation method of levosalbutamol hydrochloride | 山东锐顺药业有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-116836069-A | Preparation method of levosalbutamol hydrochloride | 山东锐顺药业有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116693406-A | Preparation method of salbutamol sulfate | 山东锐顺药业有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116693406-B | Preparation method of salbutamol sulfate | 山东锐顺药业有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-116693406-B | Preparation method of salbutamol sulfate | 山东锐顺药业有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-116836069-B | Preparation method of levosalbutamol hydrochloride | 山东锐顺药业有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-116836069-B | Preparation method of levosalbutamol hydrochloride | 山东锐顺药业有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-116836069-A | Preparation method of levosalbutamol hydrochloride | 山东锐顺药业有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116836069-A | Preparation method of levosalbutamol hydrochloride | 山东锐顺药业有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116693406-A | Preparation method of salbutamol sulfate | 山东锐顺药业有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-116693406-A | Preparation method of salbutamol sulfate | 山东锐顺药业有限公司 | 2023-09-05 | — | — | CN | disclosed |
| WO-1999066944-A1 | METHODS FOR IDENTIFYING NOVEL MULTIMERIC AGENTS THAT MODULATE RECEPTORS | ADVANCED MEDICINE, INC. (US) | 1999-12-29 | — | — | WO | disclosed |
| WO-1999064035-A1 | β2-ADRENERGIC RECEPTOR AGONISTS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999048490-A1 | ALLOSTERIC INHIBITORS AND ACTIVATORS OF PYRUVATE KINASE | ALLOS THERAPEUTICS, INC. (US) | 1999-09-30 | — | — | WO | disclosed |
| EP-0882707-A1 | NOVEL TRICYCLIC COMPOUNDS AND DRUG COMPOSITIONS CONTAINING THE SAME | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1998-12-09 | — | — | EP | disclosed |
| CN-1159797-A | Aryloxy and arylthiopropanolamine derivative suseful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof | SMITHKLINE BEECHAM PLC (GB) | 1997-09-17 | — | — | CN | disclosed |
| EP-0772585-A1 | ARYLOXY AND ARYLTHIOPROPANOLAMINE DERIVATIVES USEFUL AS BETA 3-ADRENORECEPTOR AGONISTS AND ANTAGONISTS OF THE BETA 1 AND BETA 2-ADRENORECEPTORS AND PHARMACEUTICAL COMPOSITION THEREOF | SMITHKLINE BEECHAM PLC (GB) | 1997-05-14 | — | — | EP | disclosed |
| US-5599974-A | ALDEHYDE AND ACID CONTAINING COMPOUNDS BOND WITH VALINE, ARGININE, AND LYSINE OF HEMOGLOBIN MOLECULE TO MODIFY MOLECULE | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1997-02-04 | — | — | US | disclosed |
| WO-1996004233-A1 | ARYLOXY AND ARYLTHIOPROPANOLAMINE DERIVATIVES USEFUL AS BETA 3-ADRENORECEPTOR AGONISTS AND ANTAGONISTS OF THE BETA 1 AND BETA 2-ADRENORECEPTORS AND PHARMACEUTICAL COMPOSITION THEREOF | SMITHKLINE BEECHAM PLC (GB) | 1996-02-15 | — | — | WO | disclosed |